Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 06, 2023 07:53 ET | Source: STRATA Skin Sciences, Inc.

STRATA Skin Sciences Secures Additional $12 Million Financing with MidCap Financial

HORSHAM, Pa., July 06, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for...
January 10, 2022 07:00 ET | Source: PDS Biotechnology Corporation

PDS Biotech Granted Patent for its Novel HPV16 Immunotherapy

FLORHAM PARK, N.J., Jan. 10, 2022 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies based on the Company’s...
January 05, 2022 08:00 ET | Source: PDS Biotechnology Corporation

PDS Biotechnology to Present at H.C. Wainwright Bioconnect Virtual Conference

FLORHAM PARK, N.J., Jan. 05, 2022 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies based on the Company’s...
December 23, 2021 16:00 ET | Source: PDS Biotechnology Corporation

PDS Biotech Reports An Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

FLORHAM PARK, N.J., Dec. 23, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease...
December 06, 2021 08:30 ET | Source: PDS Biotechnology Corporation

PDS Biotech Provides Recruitment update for National Cancer Institute-Led Phase 2 Clinical Trial of PDS0101-Based Combination

FLORHAM PARK, N.J., Dec. 06, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies based on the Company’s...
May 12, 2021 08:00 ET | Source: PDS Biotechnology Corporation

PDS Biotechnology Announces Participation in Noble Capital Markets C-Suite Interview Series

FLORHAM PARK, N.J., May 12, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease...
April 29, 2021 08:30 ET | Source: PDS Biotechnology Corporation

PDS Biotech Announces Oral Presentation of PDS0101 Data by the National Cancer Institute at 2021 American Society of Clinical Oncology Annual Meeting

FLORHAM PARK, N.J., April 29, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious...
April 26, 2021 16:15 ET | Source: PDS Biotechnology Corporation

PDS Biotechnology Announces Conference Call and Webcast for First Quarter Financial Results

FLORHAM PARK, N.J., April 26, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease...
August 10, 2016 16:01 ET | Source: Alimera Sciences, Inc.

Alimera Sciences Proposes Public Offering of Common Stock

ATLANTA, Aug. 10, 2016 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (NASDAQ:ALIM) (Alimera), a pharmaceutical company that specializes in research, development and commercialization of...